Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai, China.
AJNR Am J Neuroradiol. 2012 Aug;33(7):1305-9. doi: 10.3174/ajnr.A2977. Epub 2012 Apr 5.
TCCFs are a common complication following craniofacial trauma and are usually treated by coils or detachable balloons. The use of the liquid embolic agent Onyx as the sole agent for the treatment of TCCFs has been rarely reported. Herein, we summarized the preliminary experience and effectiveness of treating TCCFs with Onyx in 23 patients.
From the 36 type A CCFs treated in our department between September 2005 and March 2011, a total of 23 posttraumatic direct CCFs were treated by using Onyx only via transarterial approach.
Immediate postprocedural angiograms demonstrated complete occlusion in all patients. All the patients underwent a single procedure except 1 with bilateral TCCFs. Up to 24-month clinical and 3-month angiographic follow-ups revealed an ongoing complete occlusion without any complications.
In this series, the use of Onyx for the transarterial embolization of TCCFs was feasible and effective. Associated adverse events were rare.
创伤性颅面交通性瘘(TCCFs)是颅面创伤的常见并发症,通常采用线圈或可分离球囊进行治疗。Onyx 这种液体栓塞剂作为唯一的治疗 TCCFs 的药物,其应用很少有报道。在此,我们总结了使用 Onyx 治疗 23 例 TCCFs 的初步经验和效果。
2005 年 9 月至 2011 年 3 月,我们科室共治疗了 36 例 A 型 CCFs,其中共 23 例创伤性直接 CCFs 采用经动脉途径单纯使用 Onyx 进行治疗。
所有患者即刻行血管造影均显示完全闭塞。除 1 例双侧 TCCFs 患者外,所有患者均行单次治疗。24 个月的临床随访和 3 个月的血管造影随访显示,完全闭塞持续存在,无任何并发症。
在本系列中,经动脉栓塞治疗 TCCFs 使用 Onyx 是可行且有效的。相关不良事件罕见。